Free Trial

Oracle (ORCL) Stock Forecast & Price Target

Oracle logo
$192.29 -0.14 (-0.07%)
(As of 11/22/2024 ET)

Oracle - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
11
Buy
18

Based on 29 Wall Street analysts who have issued ratings for Oracle in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 29 analysts, 11 have given a hold rating, and 18 have given a buy rating for ORCL.

Consensus Price Target

$169.52
-11.84% Downside
According to the 29 analysts' twelve-month price targets for Oracle, the average price target is $169.52. The highest price target for ORCL is $210.00, while the lowest price target for ORCL is $120.00. The average price target represents a forecasted downside of -11.84% from the current price of $192.29.
Get the Latest News and Ratings for ORCL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Oracle and its competitors.

Sign Up

ORCL Analyst Ratings Over Time

TypeCurrent Forecast
11/23/23 to 11/22/24
1 Month Ago
10/24/23 to 10/23/24
3 Months Ago
8/25/23 to 8/24/24
1 Year Ago
11/23/22 to 11/23/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
18 Buy rating(s)
19 Buy rating(s)
17 Buy rating(s)
15 Buy rating(s)
Hold
11 Hold rating(s)
11 Hold rating(s)
13 Hold rating(s)
11 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$169.52$168.52$145.83$124.23
Forecasted Upside-11.84% Downside-2.65% Downside4.77% Upside6.87% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

ORCL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ORCL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Oracle Stock vs. The Competition

TypeOracleComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.62
2.68
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside-12.08% Downside553.16% Upside8.52% Upside
News Sentiment Rating
Positive News

See Recent ORCL News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/15/2024KeyCorp
3 of 5 stars
 Boost TargetOverweight ➝ Overweight$190.00 ➝ $200.00+6.91%
10/23/2024Royal Bank of Canada
4 of 5 stars
R. Jaluria
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSector Perform$165.00-5.89%
10/18/2024UBS Group
4 of 5 stars
 Reiterated RatingMarket Outperform ➝ Market Outperform
10/18/2024JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
P. Walravens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetMarket Outperform ➝ Market Outperform$175.00 ➝ $205.00+16.21%
9/30/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$201.00 ➝ $202.00+19.71%
9/16/2024Melius Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
9/16/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$170.00 ➝ $190.00+10.16%
9/13/2024Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$185.00 ➝ $200.00+23.95%
9/11/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$140.00 ➝ $157.00+0.36%
9/10/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMarket Perform ➝ Market Perform
9/10/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$135.00 ➝ $155.00-1.14%
9/10/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$160.00 ➝ $172.00+9.48%
9/10/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$160.00 ➝ $175.00+9.88%
9/10/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$170.00 ➝ $185.00+16.16%
9/10/2024DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$105.00 ➝ $140.00-12.09%
9/10/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$165.00 ➝ $180.00+28.65%
9/10/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$150.00 ➝ $175.00+25.08%
9/10/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$155.00 ➝ $175.00+25.08%
9/10/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$125.00 ➝ $145.00+3.64%
9/10/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform ➝ Market Perform$160.00 ➝ $173.00+23.65%
9/9/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$110.00 ➝ $120.00-15.12%
6/18/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$145.00 ➝ $159.00+11.83%
6/17/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$150.00 ➝ $165.00+18.39%
3/13/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$144.00 ➝ $155.00+21.42%
3/13/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$115.00 ➝ $130.00+1.83%
3/12/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Naji
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform
12/22/2023Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Hold
12/12/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$140.00 ➝ $130.00+12.96%
11/13/2023Edward Jones
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
9/21/2023Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$82.50 ➝ $110.00-2.54%
9/14/2023DZ Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$125.00+11.77%
9/12/2023Monness Crespi & Hardt
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
6/13/2023VNET Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
3/15/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Sami Badri
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set TargetOutperform$115.00+36.00%
3/10/2023Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
12/13/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$98.00 ➝ $96.00+17.47%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 07:59 PM ET.


Should I Buy Oracle Stock? ORCL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, November 21, 2024. Please send any questions or comments about these Oracle pros and cons to contact@marketbeat.com.

Oracle
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Oracle:

  • Oracle's stock price is currently at $192.43, reflecting a strong performance and investor confidence in the company's growth potential.
  • The company reported earnings of $1.39 per share, exceeding analysts' expectations, which indicates robust financial health and operational efficiency.
  • Oracle has a high return on equity of 171.38%, suggesting that it effectively generates profit from its equity investments, a positive sign for potential investors.
  • Recent upgrades from analysts, including a price target increase to $200.00, indicate a bullish outlook on Oracle's future performance.
  • With 42.44% of its stock owned by institutional investors, there is a level of confidence from large financial entities, which can be a positive indicator for retail investors.

Oracle
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Oracle for these reasons:

  • Oracle has a high debt-to-equity ratio of 6.68, which may indicate that the company is heavily reliant on debt financing, potentially increasing financial risk.
  • The current ratio and quick ratio are both at 0.72, suggesting that Oracle may face challenges in meeting its short-term liabilities, which could be a concern for liquidity.
  • Despite recent positive earnings, the stock has a high price-to-earnings (P/E) ratio of 50.24, which may suggest that the stock is overvalued compared to its earnings, posing a risk for investors.
  • Recent selling by hedge funds, such as Foundry Partners LLC reducing its position by 18.7%, may signal a lack of confidence among some institutional investors.
  • Market volatility, as indicated by a beta of 1.02, suggests that Oracle's stock price may fluctuate with the market, which could pose risks for investors seeking stability.

ORCL Forecast - Frequently Asked Questions

According to the research reports of 29 Wall Street equities research analysts, the average twelve-month stock price forecast for Oracle is $169.52, with a high forecast of $210.00 and a low forecast of $120.00.

29 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Oracle in the last year. There are currently 11 hold ratings and 18 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ORCL shares.

According to analysts, Oracle's stock has a predicted downside of -11.84% based on their 12-month stock forecasts.

Over the previous 90 days, Oracle's stock had 3 upgrades by analysts.

Analysts like Oracle less than other "computer and technology" companies. The consensus rating score for Oracle is 2.62 while the average consensus rating score for "computer and technology" companies is 2.67. Learn more on how ORCL compares to other companies.


This page (NYSE:ORCL) was last updated on 11/22/2024 by MarketBeat.com Staff
From Our Partners